Both in Pharmaceuticals
ABVC BioPharma vs NextCure
Over the past year ABVC returned −64.5% and NXTC returned −48.5%; their daily moves had a correlation of 0.03.
ABVC −64.5% NXTC −48.5%Growth of $1, one year, split-adjusted
| Metric | ABVC | NXTC |
|---|---|---|
| Price | $1.00 | $6.31 |
| Market cap | $26.7M | $28.9M |
| Today | −3.85% | −3.29% |
| 1 month | −2.0% | +27.2% |
| 6 months | −2.9% | −32.6% |
| Year to date | −53.1% | −55.5% |
| 1 year | −63.9% | −47.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.9K | $20.1M |
| Dividend yield | — | — |
| Volatility (60d) | 79.2% | 113.8% |
| Short % of float | 2.7% | 8.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).